1. Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non–Small Cell Lung Cancer 
Patrick Wald, MD, Xiaokui Mo, PhD, Christian Barney, MD, Daniel Gunderson, MS, A. Karl Haglund, MD, PhD, Jose Bazan, MD, John Grecula, MD, Arnab Chakravarti, MD, Terence Williams, MD, PhD, David P. Carbone, MD, PhD, Meng Xu-Welliver, MD, PhD 
Journal of Thoracic Oncology 
Volume 12, Issue 12, Pages (December 2017)
DOI: /j.jtho
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Median and mean gross tumor volumes (GTV) at each time point during treatment course.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Kaplan-Meier curves for overall survival (OS) (A), progression-free survival (PFS) (B), locoregional failure-free survival (C), and distant metastasis–free survival on the basis of GTVfraction 1–fraction 21/GTVfraction 1 dichotomized about the median (D).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

4. Figure 3
Kaplan-Meier curves for overall survival (OS) (A), progression-free survival (PFS) (B), locoregional failure-free survival (C), and distant metastasis-free survival based on GTVfraction 11–fraction 21/GTVfraction 11 dichotomized about the median (D).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions